Oruka's ORKA-001 achieves complete skin clearance in 61% of high-dose patients in Phase 2b psoriasis trial

Bitget2026/10/26 11:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Oruka Therapeutics announced positive Phase 2b EVERLAST-B results for ORKA-001 in moderate-to-severe plaque psoriasis, supporting planned Phase 3 development.
The highest dose produced complete skin clearance in most patients, with results consistent with the earlier EVERLAST-A trial.
Treatment was well tolerated, with no serious treatment-emergent adverse events in the high-dose group.
Phase 3 trials are planned for the first half of 2027, pending regulatory discussions.
Longer-term results are expected from EVERLAST-A in December 2026, followed by EVERLAST-B in the second half of 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610260700PRIMZONEFULLFEED9852808) on October 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03